hexamethonium has been researched along with Brain Neoplasms in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GUIDETTI, B | 1 |
ALVISI, C | 1 |
Nelson, ME | 1 |
Lindstrom, J | 1 |
2 other studies available for hexamethonium and Brain Neoplasms
Article | Year |
---|---|
[Hexamethonium in neurosurgery and neurology].
Topics: Analgesia; Anesthesia; Anesthesia and Analgesia; Brain; Brain Neoplasms; Hexamethonium; Hypotension; | 1954 |
Single channel properties of human alpha3 AChRs: impact of beta2, beta4 and alpha5 subunits.
Topics: Animals; Brain Neoplasms; Electrophysiology; Hexamethonium; Humans; Kinetics; Mecamylamine; Neurobla | 1999 |